Evidence map›Paper›PMID 38659767›Full record

ArticlebioRxiv : the preprint server for biology2024

Arteriolar degeneration and stiffness in cerebral amyloid angiopathy are linked to β-amyloid deposition and lysyl oxidase.

Lissa Ventura-Antunes, Alex Nackenoff, Wilber Romero-Fernandez, Allison M Bosworth, Alex Prusky, Emmeline Wang, Cristian Carvajal-Tapia, Alena Shostak, Hannah Harmsen, Bret Mobley and 6 more

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Lissa Ventura-AntunesDepartment of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID 0000-0001-5508-0990
Alex NackenoffDepartment of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID 0000-0002-6763-1953
Wilber Romero-FernandezDepartment of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID 0000-0001-9868-8074
Allison M BosworthDepartment of Biomedical Engineering, Vanderbilt University, Nashville, TN, USA.
Alex PruskyDepartment of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA.
Emmeline WangDepartment of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA.
Cristian Carvajal-TapiaDepartment of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID 0000-0002-5590-6905
Alena ShostakDepartment of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA.
Hannah HarmsenDepartment of Pathology, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID 0000-0003-2634-0321
Bret MobleyDepartment of Pathology, Vanderbilt University Medical Center, Nashville, TN, USA.
Jose MaldonadoVanderbilt Neurovisualization Lab, Vanderbilt University, Nashville, TN, USA.ORCID 0000-0002-8008-7059
Elena SolopovaDepartment of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID 0000-0001-5508-0368
J Caleb SniderDepartment of Biomedical Engineering, Vanderbilt University, Nashville, TN, USA.
W David MerrymanDepartment of Biomedical Engineering, Vanderbilt University, Nashville, TN, USA.
Ethan S LippmannDepartment of Biomedical Engineering, Vanderbilt University, Nashville, TN, USA.
Matthew SchragDepartment of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID 0000-0001-7048-0503
Vanderbilt University Medical Center · USVanderbilt University · US

Funding

Cerebral Microvascular Network Alterations in Alzheimer's Disease and Cerebral Amyloid AngiopathyR03NS111486 · NINDS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI SCHRAG, MATTHEW · 2019 to 2019
$340k
NINDS NIH HHS R03 NS111486
6 · The paper itself

Abstract

Cerebral amyloid angiopathy (CAA) is a vasculopathy characterized by vascular β-amyloid (Aβ) deposition on cerebral blood vessels. CAA is closely linked to Alzheimer's disease (AD) and intracerebral hemorrhage. CAA is associated with the loss of autoregulation in the brain, vascular rupture, and cognitive decline. To assess morphological and molecular changes associated with the degeneration of penetrating arterioles in CAA, we analyzed post-mortem human brain tissue from 26 patients with mild, moderate, and severe CAA end neurological controls. The tissue was optically cleared for three-dimensional light sheet microscopy, and morphological features were quantified using surface volume rendering. We stained Aβ, vascular smooth muscle (VSM), lysyl oxidase (LOX), and vascular markers to visualize the relationship between degenerative morphological features, including vascular dilation, dolichoectasia (variability in lumenal diameter) and tortuosity, and the volumes of VSM, Aβ, and LOX in arterioles. Atomic force microscopy (AFM) was used to assess arteriolar wall stiffness, and we identified a pattern of morphological features associated with degenerating arterioles in the cortex. The volume of VSM associated with the arteriole was reduced by around 80% in arterioles with severe CAA and around 60% in cases with mild/moderate CAA. This loss of VSM correlated with increased arteriolar diameter and variability of diameter, suggesting VSM loss contributes to arteriolar laxity. These vascular morphological features correlated strongly with Aβ deposits. At sites of microhemorrhage, Aβ was consistently present, although the morphology of the deposits changed from the typical organized ring shape to sharply contoured shards with marked dilation of the vessel. AFM showed that arteriolar walls with CAA were more than 400% stiffer than those without CAA. Finally, we characterized the association of vascular degeneration with LOX, finding strong associations with VSM loss and vascular degeneration. These results show an association between vascular Aβ deposition, microvascular degeneration, and increased vascular stiffness, likely due to the combined effects of replacement of VSM by β-amyloid, cross-linking of extracellular matrices (ECM) by LOX, and possibly fibrosis. This advanced microscopic imaging study clarifies the association between Aβ deposition and vascular fragility. Restoration of physiologic ECM properties in penetrating arteries may yield a novel therapeutic strategy for CAA.

Indexed as

Alzheimer’s disease (AD)Cerebral amyloid angiopathy (CAA)Lysyl oxidase (LOX)three-dimensional microscopyVascular smooth muscle (VSM)β-amyloid

Identifiers

PMID38659767
PMCPMC11042178
OpenAlexW4392761414

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.